The Happy Pod: Kinder medicine for millions of cancer patients
A groundbreaking DNA test is poised to spare millions of breast cancer patients from the grueling side effects of chemotherapy, according to a major international study. The ProCigna test, which analyzes tumor DNA after surgery, can identify women who won’t benefit from chemo—two-thirds of participants in the trial could safely skip it without compromising outcomes. This marks a seismic shift in oncology, moving from one-size-fits-all treatment to precision medicine. Simultaneously, a new daily pill for advanced pancreatic cancer has doubled survival time to 13.2 months—unprecedented in a disease long considered nearly untreatable. The drug targets a mutated RAS pathway, offering hope for broader applications. Beyond medicine, the episode celebrates human resilience: a student who stepped in for a sick pianist during a La La Land concert, a Paralympian aiming to become Europe’s first disabled astronaut, and a professor with stage-four cancer who summited Everest—proof that purpose and passion can outlive even the most dire diagnoses. These stories collectively redefine what it means to live fully in the face of adversity.
Two-thirds of breast cancer patients with low ProCigna test scores can safely skip chemotherapy with no impact on survival outcomes.
The ProCigna DNA test uses tumor tissue post-surgery to predict chemo non-response, eliminating unnecessary treatment and side effects.
A new drug, Daraxin-Rakib, doubles survival for advanced pancreatic cancer patients to 13.2 months by blocking the RAS signaling pathway.
Pancreatic cancer survival has historically seen only incremental gains—this is the first treatment to double median survival.
A 21-year-old student improvised a complex piano solo during a live La La Land concert after stepping in for a sick pianist.
…and 3 more takeaways available in PodZeus
Opening: A Life-Changing Diagnosis
“If there'd been a bottle of champagne there, I would have opened it. That's how wonderful it was. It was one of the best feelings.”
The ProCigna Test: Ending Chemo Overuse
“We can now confidently define a large population of women who simply aren't going to benefit and don't need to go through all that unpleasantness for no benefit at all.”
Pancreatic Cancer Breakthrough: A 13.2-Month Survival Leap
“It's unprecedented in the world of pancreatic cancer. We normally have incremental gains with additional chemotherapy regimens that we use.”
A Student Steps In: The La La Land Piano Rescue
Sterling Nasser, a 21-year-old music student, volunteered to replace a sick pianist during a live La La Land concert, improvising a complex solo on stage.
John McFall: Europe’s First Disabled Astronaut
Paralympian and surgeon John McFall is training to become the first physically disabled person to live and work in space, challenging assumptions about astronaut eligibility.
“If there'd been a bottle of champagne there, I would have opened it. That's how wonderful it was. It was one of the best feelings.”
“But we can now confidently define a large population of women who simply aren't going to benefit and don't need to go through all that unpleasantness for no benefit at all.”
“But it was an incredible feeling of just pure joy, excitement and really a life affirmation.”
Host
Guests
Dr. Shauna Burke
person
ProCigna test
other
John McFall
person
Professor David Miles
person
Daraxin-Rakib
product
Slow Food Gardens in Africa
other
Sterling Nasser
person
La La Land concert
other
Aileen Pritchard
person
Rachna Shroff
person
Prepare for a more intense El Niño, UN warns
29m • 6/2/2026
Al Fayed abuse allegations, Co-housing, Ovarian cancer, Queens
57m • 6/4/2026
Ghana passes bill criminalising promotion of LGBTQ rights
26m • 5/30/2026
The Happy Pod: The simple plastic sheet saving lives
26m • 5/30/2026
Fans rampage after Paris St-Germain win Champions League
25m • 5/31/2026
Start discovering podcast insights today
Start with a 7-day trial and explore a growing catalog of popular podcasts. No credit card required.
No credit card required • 7-day trial • Cancel anytime